All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 18, 2026

Official filing document

Bills named in this filing 2

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Health Issues

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Medicare/Medicaid

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Taxation/Internal Revenue Code

Issues related to R&D tax credit; Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs. Issues related to reimbursement in Japan.

Budget/Appropriations

Discussions regarding implementation of medtech related provisions for FY 26.

Defense

Policies impacting third party repair of medtech.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.